CPT Code: 82610
Order Code: 94588
Tests Included: Cystatin C and Glomerular Filtration Rate, Estimated (eGFR)
ABN Requirement: No
Specimen: Serum
Volume: 1.0 mL
Minimum Volume: 0.5 mL
Container: Gel-barrier tube (SST, Tiger Top)
Collection:
- Collect and label sample according to standard protocols.
- Gently invert tube 5 times immediately after draw. DO NOT SHAKE.
- Allow blood to clot 30 minutes.
- Centrifuge for 10 minutes.
Fasting: Overnight fasting is preferred.
Transport: Store serum at 2°C to 8°C after collection and ship the same day per packaging instructions included with the provided shipping box.
Stability:
Ambient (15-25°C): 14 days
Refrigerated (2-8°C): 14 days
Frozen (-20°C): 30 days
Causes for Rejection: Specimens other than serum; improper labeling; samples not stored properly; samples older than stability limits
Methodology: Particle Enhanced Turbidimetric Immunoassay (PETIA)
Turn Around Time: 1 to 3 days
Reference Range:
Cystatin C
Age (Years) | Male (mg/L) | Female (mg/L) |
---|---|---|
<1 | Not Established | Not Established |
1-18 | 0.52-1.19 | 0.52-1.19 |
19-29 | 0.52-1.35 | 0.52-1.28 |
30-39 | 0.52-1.31 | 0.52-1.24 |
40-49 | 0.52-1.27 | 0.52-1.21 |
50-59 | 0.52-1.23 | 0.52-1.17 |
60-69 | 0.52-1.20 | 0.52-1.14 |
70-79 | 0.52-1.16 | 0.52-1.10 |
80-89 | 0.52-1.13 | 0.52-1.07 |
≥90 | Not Established | Not Established |
eGFR Non-African American | ≥60 mL/min/1.73m2 |
eGFR African American | ≥60 mL/min/1.73m2 |
Clinical Significance: Cystatin C is a non-glycosylated, low molecular weight (13,250 kD) cysteine proteinase inhibitor that is produced by all nucleated cells and found in body fluids, including serum. Since it is formed at a constant rate and freely filtered by the kidneys, its serum concentration is inversely correlated with the glomerular filtration rate (GFR); that is, high values indicate low GFRs while lower values indicate higher GFRs, similar to creatinine. The renal handling of cystatin C differs from creatinine. While both are freely filtered by glomeruli, once it is filtered, cystatin C, unlike creatinine, is reabsorbed and metabolized by the proximal renal tubules. Thus, under normal conditions, cystatin C does not enter the final excreted urine to any significant degree. The serum concentration of cystatin C remains unchanged with infections, inflammatory or neoplastic states, and is not affected by body mass, diet, or drugs. Thus, cystatin C may be a more reliable marker of renal function (GFR) than creatinine. GFR can be estimated (eGFR) from serum cystatin C utilizing an equation which includes the age and gender of the patient. The CKD-EPI cystatin C equation was developed by Inker et al, and demonstrated good correlation with measured iothalamate clearance in patients with all common causes of kidney disease, including kidney transplant recipients. Cystatin C eGFR may have advantages over creatinine eGFR in certain patient groups in whom muscle mass is abnormally high or low (for example quadriplegics, very elderly, or malnourished individuals). Blood levels of cystatin C also equilibrate more quickly than creatinine, and therefore, serum cystatin C may be more accurate than serum creatinine when kidney function is rapidly changing (for example amongst hospitalized individuals).
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.